New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 13, 2014
14:25 EDTBA, BA, LLY, LLYSenate Judiciary Committee to hold a hearing
The Subcommittee on Crime and Terrorism holds a hearing entitled, "Economic Espionage and Trade Secret Theft: Are Our Laws Adequate for Today’s Threats? with Vice President Paul Hoffman of The Boeing Company and Vice President Doug Norman of Eli Lilly & Company on May 13 at 2:30 pm. Webcast Link
News For BA;LLY From The Last 14 Days
Check below for free stories on BA;LLY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
July 16, 2014
07:05 EDTLLYEli Lilly and Immunocore partner to develop cancel therapies
Eli Lilly and Immunocore today announced they have entered into a co-discovery and co-development collaboration to research and potentially develop novel T cell-based cancer therapies. Immunocore will receive an upfront fee of $15M per program for the discovery of novel ImmTACs against jointly-selected cancer targets in order to generate preclinical candidate packages. If Lilly accepts a preclinical candidate package to develop and potentially commercialize, Immunocore will receive an opt-in fee of $10M and will have an option to continue co-development with Lilly on a cost-sharing and profit-sharing basis. If Immunocore does not exercise its option, it will be entitled to potential future significant milestone and royalty payments.
06:47 EDTBABoeing Qatar Airways finalize order for 50 777Xs
Subscribe for More Information
06:40 EDTBABoeing, Hainan Airlines announce commitment for 50 737 MAX 8s
Subscribe for More Information
06:10 EDTBABoeing, MG Aviation finalize order for two 787-9 Dreamliners
Boeing and MG Aviation finalized an order for two additional 787-9 Dreamliners, valued at $499M at current list prices. The order will support the leasing company's growing fleet of modern airplanes. MG Aviation previously placed an order for two 787-9s in 2006 and now has four unfilled 787-9s orders.
05:56 EDTBABoeing, Air Algerie announce order for two Next-Generation 737-700Cs
Subscribe for More Information
05:50 EDTBABoeing rolls out 5,000th Next Generation 737
Boeing rolled out the 5,000th Next-Generation 737 this week. The airplane is a Boeing C-40A Clipper, a modified 737-700C, that will serve as a transport aircraft for the U.S. Navy. To date, orders stand at 6,804 for Next-Generation 737s and 2,109 for 737 MAXs. Total 737 orders have surpassed 12,000 including Classics and more than 100 orders for military derivatives.
July 15, 2014
11:13 EDTLLYPerrigo retreats after analyst sees limited potential buyers
Subscribe for More Information
09:46 EDTBAGE's FES selected by SpiceJet Airlines to support entire fleet
SpiceJet Airlines has selected GE’s (GE) Flight Efficiency Services to support its fleet of 52 Boeing (BA) 737 and Bombardier Q400 aircraft. GE will provide flight data analytics and fuel management to optimize the airline’s operational efficiency with the goal of substantially reducing fuel expenses for the airline. GE will provide consultation and evaluation services with the aim of reducing the airline’s fuel consumption and carbon emissions. GE is also designing and implementing custom solutions for SpiceJet and performing on-going efficiency measurements.
08:10 EDTBACIT Group places order for 10 787-9 Boeing Dreamliners
Subscribe for More Information
08:06 EDTLLYAnthera Pharmaceuticals to host conference call
Management discusses the acquisition of Sollpura (liprotamase) for Exocrine Pancreatic Insufficiency from Eli Lilly & Company on a conference call to be held on July 15 at 8:30 am.
08:05 EDTBABoeing, CIT Group announce order for 10 additional 787-9 Dreamliners
Subscribe for More Information
07:35 EDTLLYPerrigo potential buyers list could be limited, says Jefferies
After Globes reported that Perrigo retained an investment bank to assist with a potential merger, Jefferies says the list of potential buyers could be limited since the store brand business is fundamentally a high volume, lower margin model. The firm notes U.S. companies that currently do not have large over-the-counter divisions include Bristol-Myers (BMY), Eli Lilly (LLY) and Merck (MRK). Jefferies views the merger speculation surrounding Perrigo as not surprising given the company's strong long-term fundamentals and attractive Irish domicile. It has a Buy rating on the stock with a $160 price target.
07:32 EDTBARockwell Collins' Flight Control Module selected for Boeing 777x
Subscribe for More Information
07:17 EDTBAFarnborough International to hold air show
Subscribe for More Information
07:13 EDTBABoeing could face higher than foreseen KC-46 expenses, Reuters says
Subscribe for More Information
07:04 EDTBABoeing selects BAE for Integrated Flight Control Electronics system
Boeing (BA) has selected a BAE Systems (BAESY)-led team to provide electronics for the 777X flight control system through a procurement process. The system, known as the Integrated Flight Control Electronics and the Air Data Reference Function, will control the flight surfaces of the aircraft and integrate additional functionality unique to the 777X. BAE Systems is teaming with Rockwell Collins (COL) to bring this capability to Boeing. The 777X is scheduled to begin production in 2017 and first delivery is targeted for 2020.
06:50 EDTBAGE anticipates meeting $30B air show goal, Reuters says
Subscribe for More Information
06:45 EDTBABoeing, Intrepid Aviation announce 777-300ER order valued at $1.9B
Boeing and Intrepid Aviation announced the leasing company's first direct Boeing order for six 777-300ERs, valued at $1.9B at current list prices.Intrepid also has the option to purchase an additional four 777s. If all options are exercised, the value of today's announcement could reach more than $3.2B at list prices.
06:02 EDTBABoeing, Air Lease announce 777-300ER, 737 MAX 8 order valued at $3.9B
Subscribe for More Information
05:47 EDTLLYEli Lilly announces results from five datasets from Alzheimer's disease study
Eli Lilly announced results from an analyses of five datasets evaluating the relationship between cognitive and functional impairment in patients with mild Alzheimer's disease in the natural course of the disease. Analysis findings demonstrate that cognitive deficits predict subsequent functional deficits and suggest that cognitive decline experienced by patients is followed by an observable related decline in function, consistent with previously proposed hypotheses. These data were presented today at the Alzheimer's Association International Conference 2014 in Copenhagen, Denmark as part of the featured research session, "Statistics in the Race against Alzheimer's Disease." Hong Liu-Seifert, Ph.D., study research advisor at Eli Lilly stated, "These data support the concept that decline in cognition is later reflected in changes in function. This suggests that with treatments that target the underlying neuropathology of disease, effects on function may take longer to observe in clinical studies. Currently available scales were not developed to assess subtle functional changes or treatment effects on these deficits in patients with early or mild Alzheimer's disease, and there is debate as to how much variability exists in these scales globally. Therefore, we support discussion of alternative ways to demonstrate clinical meaningfulness in early or mild Alzheimer's disease."
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use